About this trial

For children and adolescents with diabetes, the pathological process of atherosclerotic cardiovascular disease(ASCVD) can exist in early childhood and progress rapidly to subclinical ASCVD. This study intends to explore the models for the prediction of ASCVD risk in childhood and teen-age onset diabetes with different types.

Eligibility criteria

Qualifiers

Diagnosis of type 1 diabetes or type 2 diabetes

Age of onset: <18y

Enrollment age: ≥18y

Gender: male or female

Disqualifiers

Specific types of diabetes

Clinical diagnosis of diabetes is unknown, and it belongs to untyped diabetes

Pregnancy or lactation

Received glucocorticoids, immunosuppressants, non-glycemic biological agents, and cytotoxic drugs in the past 3 months; non-steroidal pain relievers or antibiotics used for more than 1 week continuously

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

300 Participants
are grouped into 2 trial groups

Locations

1
Department of Endocrinology and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao-Tong University200025, Shanghai China

Sponsors and collaborators

Shanghai Jiao Tong University School of Medicine

Lead sponsor